Sun Pharmaceuticals Industries Ltd - Share Price
SUNPHARMA
Sun Pharmaceuticals Industries LtdFinancials
Sun Pharmaceuticals Industries LtdNews & Updates
Sun Pharma in a license agreement with Ferring Pharma to introduce CARITEC in India
Jun 03,2021 01:56 PM
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC.
Board of Sun Pharmaceutical Industries recommends final dividend May 28,2021
BSE Healthcare sheds 100 pts; Sun Pharma nosedives after Q4; Metropolis, Hester stocks lead May 28,2021
Sun Pharma stock under pressure despite recording a whopping 124% yoy growth in Q4 PAT May 28,2021
Nifty Pharma sheds 1%; Sun Pharma sinks ~4% after earnings, Divis Lab outperforms May 28,2021
Sun Pharma bags patent licence for Dapagliflozin in India from AstraZeneca, acquires 'Oxra' trademarks May 28,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Sun Pharmaceuticals Industries LtdSummary & Reports
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectru... More
Registered Office
Sun Pharma Advanced Res.Centre,Tandalja,Vadodara, Gujarat,390020
Tell. : +91-265-6615500
Website : http://www.sunpharma.com
Email : secretarial@sunpharma.com
Registrar Office
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in
Reports by sun-pharmaceuticals-industries-ltd-share-price
Latest Release by sun-pharmaceuticals-industries-ltd-share-price
Result Express
Jun 22, 2021 08:23 AM
The company’s consolidated revenue stood at Rs8,259.30cr, up 15.7% yoy and 17.2% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 54.48% |
| Total Promoter | 54.48% |
| Non Promoter | - |
| Institutions | 33.29% |
| Non-Institutions | 12.23% |
| Total Non-Promoter | 45.52% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
27 May 2021
Annc. Date
10 May 2021
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the... More
Purpose
EGM
Exp. Date
16 Mar 2021
Annc. Date
05 Feb 2021
COM 16/03/2021Please find enclosed respective Notices of NCLT Convened Meeting of equity shareholder... More
Purpose
Dividend
Annc. Date
29 Jan 2021
Effective. Date
09 Feb 2021
Divi. Type
Interim
Divi.(%)
550
Divi. Amt.
5.5
The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and pai... More
